Delayed radiation versus usual timing for certain brain tumors
Part of Cancer clinical trials.
This trial studies whether delaying radiation therapy helps people with a slow-growing brain tumor called low-grade oligodendroglioma that has specific genetic markers. It compares delayed radiation to standard timing to see which approach controls the tumor with acceptable side effects and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your tumor must match a specific set of tumor genetics: 1p and 19q co-deletion, and IDH-mutant (IDH1 or IDH2).
- Your diagnosis must be confirmed as low-grade oligodendroglioma by a specialized review (WHO 2016).
- You should not have had any prior radiation or chemotherapy for your brain tumor.
- Your brain MRI after any surgery must not show signs of the tumor becoming more aggressive (no new concerning enhancement and no clear fast growth).
- You must be well enough to participate: Karnofsky score of 60 or higher, and recent blood tests meet required minimums; pregnancy test is required for women who can become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation—proton therapy versus photon (standard) therapy—for adults with an IDH-mutated grade 2 or 3 brain tumor. The goal is to see which approach works better and/or causes fewer side effects while treating the tumor.
This Phase 3 study tests a treatment plan after surgery to improve brain function and quality of life in adults with newly diagnosed, specific types of brain tumors (gliomas). It may help you keep thinking clearly and living better while your tumor is treated with standard medicines.
This Phase 2 study tests a combination of chemotherapy and radiation after surgery for certain brain tumors that are “IDH wildtype.” It aims to control the tumor and improve outcomes for people with specific types of glioma or glioblastoma.
This trial tests whether adding temozolomide chemotherapy after radiation helps control a type of low-grade brain tumor that was not fully removed. It may help reduce the chance the tumor comes back, compared with standard post-radiation care.
This trial compares two types of radiation therapy (proton beams vs. standard photon x-rays) for people with certain slow-growing brain tumors (gliomas) that have a specific gene change. The goal is to see which type better preserves thinking skills and quality of life while treating the tumor.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
Hear when a new Oligodendroglioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.